Scopri cosa sono gli Tamoxifen Citrate GENESIS

Gli Tamoxifen Citrate GENESIS sono un farmaco utilizzato per trattare il cancro al seno, in particolare il tumore al seno avanzato o metastatico. Questo farmaco è Tamoxifen Citrate GENESIS un antiestrogeno che agisce bloccando l’azione degli estrogeni nel corpo. Gli estrogeni sono ormoni femminili che possono favorire la crescita delle cellule tumorali nel seno.

Come funzionano gli Tamoxifen Citrate GENESIS?

Il principio attivo del farmaco, il citrato di tamoxifene, si lega ai recettori degli estrogeni nelle cellule tumorali, impedendo loro di ricevere i segnali degli estrogeni. In questo modo, il tamoxifene riduce la capacità delle cellule tumorali di crescere e dividersi. Questo può contribuire a rallentare la progressione del tumore e a ridurre il rischio di recidiva.

Quali sono gli effetti collaterali degli Tamoxifen Citrate GENESIS?

Come tutti i farmaci, anche gli Tamoxifen Citrate GENESIS possono causare effetti collaterali. Alcuni dei più comuni includono vampate di calore, secchezza vaginale, dolori articolari e muscolari, affaticamento e perdita di capelli. È importante consultare il medico se si verificano effetti collaterali spiacevoli o persistenti.

In conclusione, gli Tamoxifen Citrate GENESIS sono un farmaco efficace nel trattamento del cancro al seno, ma è importante seguirne attentamente le indicazioni del medico e informarlo di eventuali effetti collaterali. Consultare sempre un professionista sanitario prima di iniziare qualsiasi terapia con questo farmaco.

Email us Now for Inquires

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